Skin Concerns · July 15, 2026 · 5 min · By Hugo Lindenbaum
Melasma and Lasers in Beverly Hills: Why the Most Aggressive Option Is Usually the Wrong One
Laser energy can lighten melasma fast and then bring it back darker. A plain-English look at the biology behind the rebound, which devices clinicians actually reach for, and the questions to ask before anyone fires a laser at your face.
Walk into almost any aesthetic practice in Beverly Hills and you will find a laser that can visibly lighten melasma in a single session. That is not the hard part. The hard part, and the part patients are rarely told up front, is keeping the pigment from returning weeks later, often darker and more stubborn than before. The myth worth checking is simple: melasma is not a stain that a laser can erase. It is a chronic, relapsing condition of overactive pigment cells, and treating it like sun damage or a tattoo is one of the most common reasons patients end up worse off.
Start with the mechanism. Melasma involves melanocytes, the pigment-producing cells, that have become hyperresponsive to triggers: ultraviolet light, visible light, heat, hormones, and inflammation. When a high-energy laser destroys the pigment those cells have already made, the cells themselves usually survive. Worse, the thermal injury and inflammation from the treatment can act as a fresh trigger, prompting the melanocytes to produce even more melanin. Dermatologists call this rebound hyperpigmentation, and it explains the familiar arc of dramatic early clearing followed by a darker relapse two to eight weeks later. For an independent overview, see Melasma and pigmentation: diagnosis and treatment.
This is why the devices most associated with impressive before-and-after photos, fully ablative CO2 and high-fluence intense pulsed light, carry real risk here. Both deliver significant heat. Both create inflammation. In skin already primed to overproduce pigment, that combination is closer to fuel than to treatment. Intense pulsed light deserves special caution: it can look like it is working because it targets pigment broadly, but studies and clinical experience have repeatedly shown high relapse and worsening rates in melasma, particularly in medium to darker skin tones, Fitzpatrick types III to VI, which describe a large share of patients in Los Angeles.
So what do experienced clinicians actually use? The pattern across credible practices is consistent: low energy, gentle settings, more sessions, and lasers as a supporting player rather than the star. The most commonly cited option is the low-fluence 1064 nanometer Q-switched or picosecond Nd:YAG, sometimes called laser toning. The 1064 wavelength penetrates deeply and is relatively sparing of the surface, and at low fluence it fragments pigment gradually without provoking a strong inflammatory response. Even so, overuse carries its own documented risk: guttate hypopigmentation, small white spots from exhausted or damaged melanocytes, which is why responsible protocols space sessions out and cap the total number.
Non-ablative fractional lasers, particularly the 1927 nanometer thulium wavelength, are another evidence-supported tool. They create microscopic columns of controlled injury that help shuttle pigment out of the skin and improve penetration of topical medications, again at conservative settings. Picosecond lasers with fractionated handpieces occupy similar territory: shorter pulses mean more photoacoustic effect and less heat, which is theoretically friendlier to melasma-prone skin, though the evidence base is still maturing and results depend heavily on operator settings.
Here is the part that separates a clinician-grade plan from a menu item: lasers alone do not manage melasma. The published data and standard dermatologic practice both place topicals first. Hydroquinone-based combination creams, or non-hydroquinone alternatives such as azelaic acid and cysteamine, address the overproduction problem directly. Oral tranexamic acid, prescribed and monitored by a physician for appropriate candidates, has become a common adjunct because it interrupts one of the signaling pathways that drives melanocyte activation. And sun protection is not a footnote. Because visible light, not just ultraviolet, stimulates melasma, tinted mineral sunscreens containing iron oxides matter specifically. A patient who gets flawless laser toning but drives home on the 405 with bare skin and a sunroof is running the experiment in reverse.
A few practical questions can quickly reveal whether a practice understands this condition. Ask whether they use a Wood's lamp or similar assessment to gauge pigment depth, since dermal melasma responds less predictably than epidermal. Ask what topical regimen they expect you to be on before and after laser sessions. Ask how they define success: honest answers describe control and maintenance, not cure. And ask what happens if you rebound, because a plan that has no answer for relapse is not a plan.
The bottom line for anyone comparing options in Beverly Hills: the sophistication of a melasma treatment is measured not by the power of the device but by the restraint of the protocol. Gentle wavelengths, low energy, medical topicals, oral adjuncts where appropriate, and rigorous photoprotection outperform any single dramatic session. Melasma rewards patience and punishes aggression, and the practices worth your money are the ones that say so before you sit in the chair.
Related reading: Can Laser Make Melasma Worse? A Myth Check.
